Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PAROXETINE | 30MG | TABLET | Resolved | 2018-06-04 | 2018-07-25 | 51194 |
APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-07-11 | 2018-08-30 | 55270 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2018-08-09 | 2018-11-23 | 57775 |
APO-OXAZEPAM | 30MG | TABLET | Resolved | 2018-12-12 | 2019-01-28 | 69455 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-01-09 | 2019-03-16 | 71668 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-01-09 | 2019-02-01 | 71676 |
APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77858 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-03-05 | 2019-04-05 | 77893 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-03-27 | 2019-04-26 | 79583 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2019-05-15 | 2019-06-01 | 84118 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-05-15 | 2019-08-19 | 84125 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-06-12 | 2019-08-19 | 86282 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-09-04 | 2019-12-19 | 92981 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-10-02 | 2019-12-09 | 95235 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-02-05 | 2020-02-18 | 105348 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-03-27 | 2020-05-04 | 109681 |
APO-PAROXETINE | 30MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111943 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-06-04 | 2020-09-01 | 116539 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126260 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126263 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |